Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Gynecology

  Free Subscription


24.03.2025

7 Acta Obstet Gynecol Scand
1 Am J Obstet Gynecol
1 Am J Surg Pathol
2 Aust N Z J Obstet Gynaecol
6 BMC Cancer
1 BMJ
1 Br J Cancer
1 Br J Radiol
3 Clin Cancer Res
1 Eur J Cancer
14 Eur J Obstet Gynecol Reprod Biol
1 Fertil Steril
1 Gynecol Endocrinol
8 Gynecol Oncol
3 Hum Reprod
2 Int J Cancer
10 Int J Gynaecol Obstet
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 Lancet
8 Obstet Gynecol
2 Oncogene
2 PLoS One
2 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. MATRASZEK VV, Krofta L, Hromadnikova I
    Even low levels of anticardiolipin antibodies are associated with pregnancy-related complications: A monocentric cohort study.
    Acta Obstet Gynecol Scand. 2025 Mar 17. doi: 10.1111/aogs.15096.
    PubMed         Abstract available

  2. NETHERY E, Pickerill K, Butska L, Turner M, et al
    Perinatal outcomes following nonadherence to guideline-based screening for gestational diabetes: A population-based cohort study.
    Acta Obstet Gynecol Scand. 2025 Mar 17. doi: 10.1111/aogs.15098.
    PubMed         Abstract available

  3. YANG L, Tian T, Yang X, Guo Y, et al
    A comparison of the treatment outcome of Asherman's syndrome which developed within and outside the puerperal period: A matched cohort study.
    Acta Obstet Gynecol Scand. 2025;104:774-780.
    PubMed         Abstract available

  4. BERGQVIST L, Virtanen A, Kalliala I, Butzow R, et al
    Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study.
    Acta Obstet Gynecol Scand. 2025;104:763-773.
    PubMed         Abstract available

  5. HULSHOFF CC, Spaanderman MEA, Scholten RR, van Drongelen J, et al
    Efficacy of transabdominal cerclage by open laparotomy relative to existing risk factors.
    Acta Obstet Gynecol Scand. 2025;104:685-696.
    PubMed         Abstract available

  6. TULENHEIMO-SILFVAST A, Ruokolainen-Pursiainen L, Simberg N
    Association between iron deficiency and fertility.
    Acta Obstet Gynecol Scand. 2025;104:738-745.
    PubMed         Abstract available

  7. WAGENIUS J, Ehrstrom S, Kallen K, Baekelandt J, et al
    Why not vaginal?-Nationwide trends and surgical outcomes in low-risk hysterectomies: A retrospective cohort study.
    Acta Obstet Gynecol Scand. 2025 Mar 18. doi: 10.1111/aogs.15099.
    PubMed         Abstract available


    Am J Obstet Gynecol

  8. ALSON JG, Orellana M, Robinson WR, Williams P, et al
    Facilitators and Barriers to Acceptability of a Biopsy-First Approach in the Diagnostic Evaluation for Endometrial Cancer Among Black Women.
    Am J Obstet Gynecol. 2025 Mar 12:S0002-9378(25)00157.
    PubMed         Abstract available


    Am J Surg Pathol

  9. NORGAN AP, Enninga EAL, Fedyshyn B, Wolf M, et al
    Enterovirus Placentitis is an Underrecognized Cause of Placental Pathology.
    Am J Surg Pathol. 2025 Mar 17. doi: 10.1097/PAS.0000000000002378.
    PubMed         Abstract available


    Aust N Z J Obstet Gynaecol

  10. YASIN N, Yu M, Jones K, Woolfield A, et al
    The impact of the COVID-19 public health response on service demand and patient perceptions in a tertiary Australian gynaecology oncology unit.
    Aust N Z J Obstet Gynaecol. 2025;65:147-155.
    PubMed         Abstract available

  11. SHORT A, Sit A, Gerstl B, Mallinder H, et al
    Vaginoscopy to investigate vaginal bleeding and discharge in prepubertal girls.
    Aust N Z J Obstet Gynaecol. 2025;65:140-146.
    PubMed         Abstract available


    BMC Cancer

  12. SHIBATA K, Kajiyama H, Ino K, Nawa A, et al
    Editorial Expression of Concern: P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling.
    BMC Cancer. 2025;25:486.
    PubMed        

  13. CAI G, Zhang S, Gao S, Deng T, et al
    What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:491.
    PubMed         Abstract available

  14. MARBACH D, Brouer-Visser J, Brennan L, Wilson S, et al
    Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor).
    BMC Cancer. 2025;25:500.
    PubMed         Abstract available

  15. ZENG S, Li X, Xiao S, Yang P, et al
    Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:502.
    PubMed         Abstract available

  16. ZHOU R, Xie Y, Wang Z, Liu Z, et al
    Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and identifies a prognostic signature in cervical cancer.
    BMC Cancer. 2025;25:498.
    PubMed         Abstract available

  17. OLORUNFEMI G, Libhaber E, Ezechi OC, Musenge E, et al
    Trends in national and ethnic burden of ovarian cancer mortality in South Africa (1999-2018): a population based, age-period-cohort and join point regression analyses.
    BMC Cancer. 2025;25:515.
    PubMed         Abstract available


    BMJ


  18. Medical news in brief: Legal threat over MRCP error, new endometriosis pill, sexual assault referrals rise, and other stories.
    BMJ. 2025;388:r530.
    PubMed        


    Br J Cancer

  19. PIGNATA S, Oza A, Hall G, Pardo B, et al
    Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status.
    Br J Cancer. 2025 Mar 17. doi: 10.1038/s41416-025-02966.
    PubMed         Abstract available


    Br J Radiol

  20. KUANG JY, Tang K
    The Application Value of Ultrasound in Ovarian Hyperstimulation Syndrome and Literature Review.
    Br J Radiol. 2025 Mar 19:tqaf064. doi: 10.1093.
    PubMed         Abstract available


    Clin Cancer Res

  21. BANERJEE S, Ghisoni E, Wolfer A, Ottevanger PB, et al
    Bevacizumab, atezolizumab and acetylsalicylic acid in recurrent, platinum-resistant ovarian cancer: the EORTC 1508-GCG phase II study.
    Clin Cancer Res. 2025 Mar 18. doi: 10.1158/1078-0432.CCR-24-3368.
    PubMed         Abstract available

  22. GARG V, Oza AM
    Precision Endocrine Therapy in Endometrial Cancer: Has its time finally come?
    Clin Cancer Res. 2025 Mar 21. doi: 10.1158/1078-0432.CCR-24-3905.
    PubMed         Abstract available

  23. EERKENS AL, Esajas MD, Brummel K, Vledder A, et al
    Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.
    Clin Cancer Res. 2025;31:1016-1026.
    PubMed         Abstract available


    Eur J Cancer

  24. SIITONEN H, Joensuu J, Savolainen-Peltonen H, Gissler M, et al
    Update of the impact of menopausal hormone therapy on breast cancer risk.
    Eur J Cancer. 2025;220:115340.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  25. TELLIER F, Vignozzi E, Ramanah R, Mottet N, et al
    Evaluation of the quality and reliability of YouTube videos on obstetric perineal tears.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:228-233.
    PubMed         Abstract available

  26. GRIFFIN MM, Penfield CA, Hausvater A, Schaap A, et al
    The relationship between platelet indices and hypertensive disorders of pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:234-239.
    PubMed         Abstract available

  27. JUNAID F, Davies B, Tariq S, Zamora J, et al
    Seizure prediction in pregnant women with epilepsy: An umbrella review of clinical practice guidelines and systematic reviews.
    Eur J Obstet Gynecol Reprod Biol. 2025;308:241-250.
    PubMed         Abstract available

  28. KRIPLANI I, Choudhary N, Kriplani A, Sharma S, et al
    Retrograde filling of non-communicating horn of Robert's uterus for successful hysteroscopic metroplasty - Surgical technique innovation.
    Eur J Obstet Gynecol Reprod Biol. 2025 Feb 11:S0301-2115(25)00083.
    PubMed        

  29. MASCI J, Kandel M, Walker SP, Cannon P, et al
    Alpha-fetoprotein (AFP) is reduced at 36 weeks' gestation in pregnancies destined to deliver small for gestational age infants.
    Eur J Obstet Gynecol Reprod Biol. 2025 Mar 10:S0301-2115(25)00165.
    PubMed         Abstract available

  30. KANG OJ, Nam JH, Park JY
    Comparison of single-site and three-port hysterectomy for benign uterine diseases: A randomised trial (LESS-H).
    Eur J Obstet Gynecol Reprod Biol. 2025;308:251-256.
    PubMed         Abstract available

  31. TSIAPAKIDOU S, Mukhopadhyay S, Louwen F, Mahmood T, et al
    Workforce wellbeing in European Healthcare: Challenges and strategic actions based on a questionnaire-based study by the European Board and College of Obstetrics and Gynaecology.
    Eur J Obstet Gynecol Reprod Biol. 2025 Mar 10:S0301-2115(25)00167.
    PubMed        

  32. MORCH EJ, Perslev K, Wronding T, Aabakke A, et al
    Counseling women with obstetric anal sphincter injury - Risk of recurrence and the influence of mode of second delivery on subsequent anal incontinence - A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:14-22.
    PubMed         Abstract available

  33. TAITTONEN L, Makynen T, Erkinheimo TL
    Immediate skin-to-skin contact during cesarean section - A pilot study with simulation characters.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:23-26.
    PubMed         Abstract available

  34. PFEIFFER AF, Chang N, Zarudskaya O, Cheng C, et al
    IV iron supplementation, dosage, and timing in pregnancy: A single-institution review on a maternal transfusion reduction bundle.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:42-47.
    PubMed         Abstract available

  35. DITTO A, Fucina S, Chiarello G, Bogani G, et al
    An effective surgical approach to treat obese patients with gynecological disease using a subcutaneous abdominal wall-retraction device to perform low-pressure laparoscopy: A prospective, single-center study.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:55-60.
    PubMed         Abstract available

  36. MALER S, Axelsson K, Utjes D, Abrahamsson T, et al
    Residual placental blood volume after cesarean section: A scoping review.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:65-72.
    PubMed         Abstract available

  37. SHI G, Wang C, Lu Y, Zhang P, et al
    Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei originating from ovarian teratomas: A single-center case series and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:107-112.
    PubMed         Abstract available

  38. LI X, Zhang Z, Li Y, Zhao C, et al
    Assessment of pelvic floor dysfunction after total hysterectomy: A preliminary study based on transperineal ultrasound and shear wave elastography.
    Eur J Obstet Gynecol Reprod Biol. 2025;309:113-120.
    PubMed         Abstract available


    Fertil Steril

  39. WAHLSTEDT J, Wahlstedt E, Ramsay J, Woodcock A, et al
    A Nationwide Analysis of the Trends in Permanent Contraception Utilization Before and After the Dobbs Ruling.
    Fertil Steril. 2025 Mar 18:S0015-0282(25)00161.
    PubMed        


    Gynecol Endocrinol

  40. CAGNACCI A, Gambacciani M, Lello S, Paoletti AM, et al
    Indications for the use of menopausal hormone therapy after cancer: on what data should we rely on?
    Gynecol Endocrinol. 2025;41:2477504.
    PubMed        


    Gynecol Oncol

  41. ENGH A, Rueegg CS, Bjerre Trent PK, Opheim LO, et al
    Physical activity and lower extremity lymphedema among endometrial cancer survivors: A population-based cross-sectional study.
    Gynecol Oncol. 2025;195:82-88.
    PubMed         Abstract available

  42. SALINARO J, Singh K, Sands N, Gill V, et al
    Distribution and concordance of HER2 scores in endometrial and ovarian cancer.
    Gynecol Oncol. 2025;195:115-121.
    PubMed         Abstract available

  43. CARUSO G, Kumar A, Langstraat CL, McGree ME, et al
    Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer.
    Gynecol Oncol. 2025;195:106-114.
    PubMed         Abstract available

  44. LI Y, Wu M, Liu Q, Huang C, et al
    Development and validation of an ovarian cancer risk assessment tool for first-degree relatives of patients in the Chinese population.
    Gynecol Oncol. 2025;195:165-172.
    PubMed         Abstract available

  45. LEE EK, Kolin DL, Matulonis UA, Erickson BK, et al
    Diagnostic and therapeutic advances for HER2-expressing or amplified gynecologic cancers.
    Gynecol Oncol. 2025;195:152-164.
    PubMed         Abstract available

  46. DE BONDT D, Naslazi E, Jansen E, Kupets R, et al
    Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies.
    Gynecol Oncol. 2025;195:134-143.
    PubMed         Abstract available

  47. DEMARI JA, Glassman D, Smith S, Darby JP, et al
    Endometrial cancer somatic testing practice patterns among gynecologic oncologists.
    Gynecol Oncol. 2025;195:149-151.
    PubMed        

  48. SULLIVAN MW, Chui MH, Selenica P, Long Roche K, et al
    Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis.
    Gynecol Oncol. 2025;195:144-148.
    PubMed         Abstract available


    Hum Reprod

  49. RIWA S, Alison M, Ann K, Quetrell H, et al
    Pregnancy outcomes with increasing maternal age, greater than 40 years, in donor oocyte cycles.
    Hum Reprod. 2025 Mar 20:deaf044. doi: 10.1093.
    PubMed         Abstract available

  50. LIN N, Zeleznik OA, Vitonis AF, Laliberte A, et al
    Plasma metabolites associated with endometriosis in adolescents and young adults.
    Hum Reprod. 2025 Mar 19:deaf040. doi: 10.1093.
    PubMed         Abstract available

  51. KATSIKA ET, Venetis CA, Bosdou JK, Kolibianakis EM, et al
    Is it justified to offer intrauterine infusion of autologous PRP in women with repeated implantation failure?
    Hum Reprod. 2025 Mar 17:deaf014. doi: 10.1093.
    PubMed         Abstract available


    Int J Cancer

  52. KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al
    High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort study.
    Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335.
    PubMed         Abstract available

  53. RUNELLO F, Jary A, Duin S, Kim Y, et al
    DNA methylation and copy number alterations in the progression of HPV-associated high-grade vulvar intraepithelial lesion.
    Int J Cancer. 2025 Feb 12. doi: 10.1002/ijc.35366.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  54. JAREEMIT N, Theerarojanapong L, Laokulrath N, Achariyapota V, et al
    Yield of endocervical curettage in detecting cervical intraepithelial neoplasia grade 2 or higher during colposcopy: A prospective, cross-sectional study.
    Int J Gynaecol Obstet. 2025;169:105-111.
    PubMed         Abstract available

  55. GUNGORDUK K, Unver HC, Uyar BS, Ergu BN, et al
    Efficacy of chitosan powder in reducing vaginal bleeding following a loop electrosurgical excision procedure: A randomized control trial.
    Int J Gynaecol Obstet. 2025;169:240-246.
    PubMed         Abstract available

  56. LV M, Jin N, Wang D, Qiu L, et al
    Longitudinal change in cervical length measured after prophylactic cerclage in predicting spontaneous preterm birth.
    Int J Gynaecol Obstet. 2025;169:356-364.
    PubMed         Abstract available

  57. BALANDYA B, Benova L, Kikula A, Pembe AB, et al
    Prevalence of infertility and its association with intimate partner violence in Tanzania: Findings from the 2022 Demographic and Health Survey.
    Int J Gynaecol Obstet. 2025;169:171-181.
    PubMed         Abstract available

  58. VAN DE LAAR RLO, Jordans CCE, Salmaan A, Hofhuis W, et al
    High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands.
    Int J Gynaecol Obstet. 2025;169:155-162.
    PubMed         Abstract available

  59. XU P, Mageswaran UM, Nisaa AA, Balasubramaniam SD, et al
    Roles of probiotics against HPV through the gut-vaginal axis.
    Int J Gynaecol Obstet. 2024 Nov 9. doi: 10.1002/ijgo.16005.
    PubMed         Abstract available

  60. GONEN N, Mor L, Rabinovich D, Kleiner I, et al
    Obstetric and neonatal outcomes in clinically diagnosed placental abruption with and without placental histopathologic confirmation-A retrospective study.
    Int J Gynaecol Obstet. 2025 Mar 20. doi: 10.1002/ijgo.70079.
    PubMed         Abstract available

  61. KHAIR M, Palamuthusingam D, Hawley CM, Pascoe EM, et al
    Gynecological surgery in patients with kidney failure on chronic kidney replacement therapy: A binational data linkage study of morbidity and mortality outcomes.
    Int J Gynaecol Obstet. 2025 Mar 17. doi: 10.1002/ijgo.70064.
    PubMed         Abstract available

  62. TYAGI A, Bodh P
    Response: Weight-based versus fixed-dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial.
    Int J Gynaecol Obstet. 2025 Mar 17. doi: 10.1002/ijgo.70084.
    PubMed        

  63. PUROSKI L, Braund S, Guerin O, Verspyck E, et al
    Gynecology residents' preparedness to perform standard gynecological procedures autonomously: A national survey among French residents and faculty.
    Int J Gynaecol Obstet. 2025 Mar 17. doi: 10.1002/ijgo.70068.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  64. RUSSO AL, Depauw N, Horick NK, Wo JY, et al
    Long Term Results of a Phase II Study of Adjuvant Proton Radiotherapy for Node-Positive Cancer of the Uterus and Cervix: Proton Radiation for Uterine/Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00238.
    PubMed         Abstract available


    J Clin Oncol

  65. MARTH C, Moore RG, Bidzinski M, Pignata S, et al
    First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.
    J Clin Oncol. 2025;43:1083-1100.
    PubMed         Abstract available

  66. MATEI DE, Enserro DM, Randall ME, Mutch D, et al
    Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
    J Clin Oncol. 2025;43:1055-1060.
    PubMed         Abstract available


    Lancet

  67. LAUDANSKI P
    Natural or artificial menstrual cycle for frozen embryo transfer.
    Lancet. 2025;405:893-894.
    PubMed        


    Obstet Gynecol

  68. DE VITIS LA, Schivardi G, Grcevich L, Capasso I, et al
    Diagnostic Algorithms for Adnexal Masses in the Hands of a Novice Operator.
    Obstet Gynecol. 2025;145:368-376.
    PubMed         Abstract available

  69. FIASTRO AE, Brown E, Smith P, Thayer EK, et al
    Telehealth Medication Abortion: Comparing Advance-Provision Patients With Pregnant Patients.
    Obstet Gynecol. 2025 Mar 20. doi: 10.1097/AOG.0000000000005886.
    PubMed         Abstract available

  70. LIANG X, Fan J
    Transcutaneous Electric Nerve Stimulation for Analgesia During Outpatient Endometrial Biopsy.
    Obstet Gynecol. 2025;145:e143.
    PubMed        

  71. GUPTA P, Srikandhan S
    Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy.
    Obstet Gynecol. 2025;145:e141-e142.
    PubMed        

  72. APELIAN S
    Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only.
    Obstet Gynecol. 2025;145:e140.
    PubMed        

  73. GIANNINI A, Golia D'Auge T, Bogani G
    Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer.
    Obstet Gynecol. 2025;145:e139.
    PubMed        

  74. LEE A, Stokes K, Goodman D, Low J, et al
    Inpatient Buprenorphine Initiation for Pregnant Patients.
    Obstet Gynecol. 2025;145:e136.
    PubMed         Abstract available

  75. VIZAN-CHAGUACEDA R, Leiros-Rodriguez R, Hernandez-Lucas P
    Efficacy of Fractionated Carbon Dioxide Laser for the Treatment of Genitourinary Syndrome of Menopause: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 Mar 20. doi: 10.1097/AOG.0000000000005885.
    PubMed         Abstract available


    Oncogene

  76. ZHAI F, Li Y, Zheng J, Yan C, et al
    SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial cancer by inducing O-dysglycosylation.
    Oncogene. 2025 Mar 17. doi: 10.1038/s41388-025-03347.
    PubMed         Abstract available

  77. WANG J, Yang F, Chen Y, Xing Y, et al
    A positive feedback loop of OTUD1 and c-Jun driven by leptin expedites stemness maintenance in ovarian cancer.
    Oncogene. 2025 Mar 19. doi: 10.1038/s41388-025-03342.
    PubMed         Abstract available


    PLoS One

  78. FALAHY EP, Pahlevan-Fallahy MT, Keikha F
    Comparing the accuracy of Pipelle versus hysteroscopy and curettage in the diagnosis of chronic endometritis in women with recurrent implantation failure: A prospective cross-sectional study.
    PLoS One. 2025;20:e0319294.
    PubMed         Abstract available

  79. BARNEKOW E, Liu W, Andersson E, Wang X, et al
    A Swedish genome-wide haplotype association analysis identifies novel candidate loci associated with endometrial cancer risk.
    PLoS One. 2025;20:e0316086.
    PubMed         Abstract available


    Urology

  80. IBIS MA, Unal S, Aydog E, Oguz ES, et al
    Correlation of 17-OH Progesterone Changes With Semen Parameters and Pregnancy Outcomes in Hypogonadal and Eugonadal Patients After Varicocelectomy.
    Urology. 2025 Mar 12:S0090-4295(25)00236-5. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available

  81. ORZEL J, Stearns G
    Reply to Editorial Comment on "Pregnancy, Fertility Implications, and Parental Leave Policies: Where Does Urology Stand?".
    Urology. 2025 Mar 18:S0090-4295(25)00263-8. doi: 10.1016/j.urology.2025.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.